Andrew MorenoVTE | June 1, 2024
Aspirin was found to be safe and effective in patients with a wide range of VTE risk who underwent total knee arthroplasty.
Read More
Patrick DalyVTE | March 22, 2024
Efficacy appeared to be similar among DOACs for managing cancer-related VTE, though apixaban may have more favorable safety.
Melissa BadamoVTE | February 12, 2024
Patients with RA had a 57% increased risk of VTE; a 58% increased risk of DVT; and a 57% increased risk of PE.
Patrick DalyHematology | November 22, 2023
Tranexamic acid did not seem to increase risk of postoperative complications in patients undergoing total joint arthroplasty.
Patrick DalyVTE | November 8, 2023
Patients treated for isolated superficial vein thrombosis with anticoagulants still had a "substantial" risk of VTE later on.
Patrick DalyVTE | November 3, 2023
MPN-associated vascular thromboembolisms were more common in JAK2-mutated diseases and less common in CALR-mutated diseases.
Patrick DalyThrombosis | October 25, 2023
Edoxaban therapy for 12 months was superior to three-month therapy for preventing venous thromboembolisms and related deaths.
Rob DillardHematology | October 3, 2023
Take a look at these important studies relevant to anemia, venous thromboembolism, sickle cell disease, and PNH.
Cailin ConnerVTE | October 2, 2023
Patients with severe LMWH are less likely to experience VTE.
Cailin ConnerNephrology Times | February 8, 2024
In the 30-day period following consultation or hospitalization for gout flares, a transient increase in the rate of ...
Patrick DalyVTE | August 30, 2023
According to authors of a recent study, venous thromboembolism (VTE) is the third most common cardiovascular disease. ...
Patrick DalyVTE | September 6, 2023
According to a study published in Lancet, the optimal dose of low-molecular-weight heparin for venous thromboembolism ...
Patrick DalyVTE | August 29, 2023
In the ORAL Surveillance study, researchers found tofacitinib showed a higher incidence of pulmonary embolism compared ...
Patrick DalyVTE | August 30, 2023
In a study, published in the European Journal of Clinical Pharmacology, researchers investigated whether Janus kinase ...
Rob DillardASCO 2022 | August 30, 2023
Researchers conducted a study to discern clinical predictors for the development of venous thromboembolism (VTE) in ...
Patrick DalyVTE | August 30, 2023
Researchers, led by Lisa Jakobsen, evaluated the relation between different prothrombotic genotypes and a high mean ...
Patrick DalyVTE | August 30, 2023
In a recent study, Paige Weaver, from the Department of Pharmacy at the Ascension Genesys Hospital in Grand Blanc, ...
Patrick DalyVTE | September 6, 2023
Apixaban has been shown to be effective for preventing venous thromboembolism (VTE) in patients with cancer, but is ...
Patrick DalyVTE | August 30, 2023
Qiongjie Zhou, MD, PhD, and colleagues from the Department of Obstetrics of the Obstetrics and Gynecology Hospital of ...
DocWire News EditorsVTE | September 6, 2023
Researchers from the Department of Medicine and the Ottawa Hospital Research Institute at the University of Ottawa in ...
Latest News

June 19, 2024